Barclays Begins Coverage on CME Group (CME)

Barclays began coverage on shares of CME Group (NASDAQ:CME) in a report published on Tuesday, MarketBeat reports. The brokerage issued an overweight rating and a $210.00 price target on the financial services provider’s stock.

A number of other research firms have also issued reports on CME. Berenberg Bank raised CME Group from a hold rating to a buy rating and set a $220.00 target price on the stock in a report on Tuesday, November 20th. Citigroup began coverage on CME Group in a report on Tuesday, November 20th. They set a buy rating and a $220.00 price objective on the stock. UBS Group lowered CME Group from a buy rating to a neutral rating and upped their price objective for the stock from $185.00 to $204.00 in a report on Wednesday, November 28th. Atlantic Securities began coverage on CME Group in a report on Wednesday, November 28th. They set a neutral rating and a $200.00 price objective on the stock. Finally, Deutsche Bank upped their price objective on CME Group from $205.00 to $206.00 and gave the stock a buy rating in a report on Friday, November 16th. Six analysts have rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock has a consensus rating of Buy and a consensus target price of $194.13.

CME opened at $189.02 on Tuesday. The company has a market cap of $63.96 billion, a price-to-earnings ratio of 39.63, a PEG ratio of 2.19 and a beta of 0.46. CME Group has a 52 week low of $143.68 and a 52 week high of $197.08. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.15.

CME Group (NASDAQ:CME) last released its earnings results on Thursday, October 25th. The financial services provider reported $1.45 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.42 by $0.03. The business had revenue of $904.20 million for the quarter, compared to analyst estimates of $910.50 million. CME Group had a return on equity of 9.18% and a net margin of 113.67%. Equities analysts predict that CME Group will post 6.65 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 27th. Investors of record on Monday, December 10th will be paid a $0.70 dividend. The ex-dividend date is Friday, December 7th. This represents a $2.80 annualized dividend and a yield of 1.48%. CME Group’s payout ratio is currently 58.70%.

In other CME Group news, Director Martin J. Gepsman sold 300 shares of the company’s stock in a transaction dated Thursday, September 13th. The stock was sold at an average price of $172.30, for a total transaction of $51,690.00. Following the completion of the sale, the director now directly owns 42,912 shares in the company, valued at $7,393,737.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Julie Winkler sold 5,847 shares of the company’s stock in a transaction dated Friday, November 16th. The stock was sold at an average price of $195.01, for a total value of $1,140,223.47. Following the sale, the insider now owns 24,255 shares of the company’s stock, valued at $4,729,967.55. The disclosure for this sale can be found here. Insiders sold 29,800 shares of company stock valued at $5,628,462 over the last quarter. Insiders own 0.43% of the company’s stock.

A number of large investors have recently made changes to their positions in CME. Marshall Wace LLP acquired a new stake in shares of CME Group in the third quarter valued at about $990,000. Belpointe Asset Management LLC acquired a new stake in shares of CME Group in the third quarter valued at about $294,000. Morgan Stanley grew its stake in shares of CME Group by 20.5% in the third quarter. Morgan Stanley now owns 1,118,708 shares of the financial services provider’s stock valued at $190,415,000 after buying an additional 190,256 shares in the last quarter. Legal & General Group Plc grew its stake in shares of CME Group by 2.2% in the third quarter. Legal & General Group Plc now owns 1,612,654 shares of the financial services provider’s stock valued at $274,515,000 after buying an additional 34,772 shares in the last quarter. Finally, Rehmann Capital Advisory Group grew its stake in shares of CME Group by 17,847.3% in the third quarter. Rehmann Capital Advisory Group now owns 280,876 shares of the financial services provider’s stock valued at $1,650,000 after buying an additional 279,311 shares in the last quarter. Institutional investors own 85.89% of the company’s stock.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Further Reading: Earnings Reports

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply